Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huandi Zhou

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Peerj|May 27, 2021
The relationship between PLOD1 expression level and glioma prognosis investigated using public databasesLei Tian, Huandi Zhou, Guohui Wang, et al.
Medicine|July 29, 2022
Meta of classical chemotherapy compared with high-dose chemotherapy and autologous stem cell rescue in newly diagnosed medulloblastoma after radiotherapyMengting Zhang, Chunmei Liu, Huandi Zhou, et al.
Frontiers in Neurology|November 10, 2022
MELK is a prognostic biomarker and correlated with immune infiltration in gliomaHaiyan Yang, Huandi Zhou, Guohui Wang, et al.
Frontiers in Oncology|August 27, 2025
CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathwayLiubing Hou, Zengyao Hao, Ge Zhang, et al.
International Journal of Endocrinology|October 3, 2022
Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative StressLin Mu, Nan Chen, Yakun Chen, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2023
The study of an anoikis-related signature to predict glioma prognosis and immune infiltrationDongdong Zhang, Yu Wang, Huandi Zhou, et al.
Disease Markers|July 5, 2022
Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of GliomaLiubing Hou, Huandi Zhou, Yanqiang Wang, et al.
Biomed Research International|August 21, 2025
Systematic Analysis of an Immune-Related Gene Signature for Predicting Prognosis and Immune Characteristics in Primary Lower Grade GliomaLiubing Hou, Lei Tian, Jiayuan Li, et al.
Frontiers in Oncology|August 1, 2022
TOP2A correlates with poor prognosis and affects radioresistance of medulloblastomaYufeng Zhang, Haiyan Yang, Liwen Wang, et al.
Journal of Clinical Medicine|June 12, 2026
Grade-Dependent Prognostic Value of Classical Clinicopathological Factors in Glioma: A Single-Center Retrospective StudyGe Zhang, Mengting Zhang, Xuetao Han, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Peerj|May 27, 2021
The relationship between PLOD1 expression level and glioma prognosis investigated using public databasesLei Tian, Huandi Zhou, Guohui Wang, et al.
Medicine|July 29, 2022
Meta of classical chemotherapy compared with high-dose chemotherapy and autologous stem cell rescue in newly diagnosed medulloblastoma after radiotherapyMengting Zhang, Chunmei Liu, Huandi Zhou, et al.
Frontiers in Neurology|November 10, 2022
MELK is a prognostic biomarker and correlated with immune infiltration in gliomaHaiyan Yang, Huandi Zhou, Guohui Wang, et al.
Frontiers in Oncology|August 27, 2025
CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathwayLiubing Hou, Zengyao Hao, Ge Zhang, et al.
International Journal of Endocrinology|October 3, 2022
Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative StressLin Mu, Nan Chen, Yakun Chen, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2023
The study of an anoikis-related signature to predict glioma prognosis and immune infiltrationDongdong Zhang, Yu Wang, Huandi Zhou, et al.
Disease Markers|July 5, 2022
Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of GliomaLiubing Hou, Huandi Zhou, Yanqiang Wang, et al.
Biomed Research International|August 21, 2025
Systematic Analysis of an Immune-Related Gene Signature for Predicting Prognosis and Immune Characteristics in Primary Lower Grade GliomaLiubing Hou, Lei Tian, Jiayuan Li, et al.
Frontiers in Oncology|August 1, 2022
TOP2A correlates with poor prognosis and affects radioresistance of medulloblastomaYufeng Zhang, Haiyan Yang, Liwen Wang, et al.
Journal of Clinical Medicine|June 12, 2026
Grade-Dependent Prognostic Value of Classical Clinicopathological Factors in Glioma: A Single-Center Retrospective StudyGe Zhang, Mengting Zhang, Xuetao Han, et al.
Pageof 6